Literature DB >> 16739882

Quantitative analysis of cyclin E and protein p34 cdc2 expression in superficial bladder cancer.

Piotr Kaczmarek1, Dariusz Tosik, Ewa Majewska, Zbigniew Baj.   

Abstract

In the present study, the expression of cyclin E and kinase p34 cdc2 was investigated in preinvasive bladder tumors. The study material consisted of bladder sections (grades: GI--16 cases, GII--10, and GIII--12) collected from 38 patients in the course of the tumor electroresection. Immunohistochemical examinations were carried out with immunoperoxidase method. Antigens were labeled with NCL-CYCLIN E or NCL-p34 cdc2 monoclonal antibodies (Novocastra, UK). Positive reaction was demonstrated using ABC-universal Kit (Novocastra, UK). Differences in the protein expression in relation to the tumor grade were determined with a non-parametric Mann-Whitney's test. Increasing grade of tumors was associated with down regulation of cyclin E visible as lower percentage of cyclin E-positive cells. These changes were statistically significant for GI group as compared to groups GII and GIII (p<0.001). There were no differences between the study groups in the p34 protein expression. Cyclin E expression was inversely correlated with tumor grade therefore may be helpful in establishing therapeutic procedure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16739882

Source DB:  PubMed          Journal:  Pol J Pathol        ISSN: 1233-9687            Impact factor:   1.072


  2 in total

1.  Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.

Authors:  Yanju Wu; Qianqian Zheng; Yan Li; Guang Wang; Shuting Gao; Xiaodong Zhang; Xu Yan; Xinwen Zhang; Jisheng Xie; Yuanyuan Wang; Xun Sun; Xin Meng; Bo Yin; Biao Wang
Journal:  J Exp Clin Cancer Res       Date:  2019-08-27

2.  Protein Profiling of Bladder Urothelial Cell Carcinoma.

Authors:  Jinghai Hu; Fei Ye; Miao Cui; Peng Lee; Chengguo Wei; Yuanyuan Hao; Xiaoqing Wang; Yanbo Wang; Zhihua Lu; Matthew Galsky; Russell McBride; Li Wang; Dongwen Wang; Carlos Cordon-Cardo; Chunxi Wang; David Y Zhang
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.